Aytu BioPharma (STU:AY20) General and Admin. Expense : €22.16 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Aytu BioPharma General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Aytu BioPharma's General and Admin. Expense for the three months ended in Mar. 2024 was €5.01 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €22.16 Mil.

Aytu BioPharma General and Admin. Expense Historical Data

The historical data trend for Aytu BioPharma's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aytu BioPharma General and Admin. Expense Chart

Aytu BioPharma Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

General and Admin. Expense

Get a 7-Day Free Trial

17.46

21.17

29.48

26.43

Aytu BioPharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
General and Admin. Expense	Get a 7-Day Free Trial															6.70	5.64	6.52	4.99	5.01

Aytu BioPharma General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €22.16 Mil.

Aytu BioPharma General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Aytu BioPharma's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Aytu BioPharma (STU:AY20) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aytu BioPharma Inc (STU:AY20) » Definitions » General and Admin. Expense

Comparable Companies

Traded in Other Exchanges

AYTU:USA

Address

7900 East Union Avenue, Suite 920, Denver, CO, USA, 80237

Website

https://www.aytubio.com

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.

Aytu BioPharma (STU:AY20) Headlines

No Headlines